​

LENSAR Stock (NASDAQ:LNSR)

RevenueOwnershipFinancialsChartTranscripts
LENSAR by TradingView

Previous Close

$5.21

52W Range

$5.06 - $14.31

50D Avg

$8.13

200D Avg

$11.04

Market Cap

$64.71M

Avg Vol (3M)

$116.71K

Beta

0.98

Div Yield

-

LNSR Company Profile

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

140

IPO Date

Oct 02, 2020

Website

LNSR Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Service$5.73M$4.90M$4.07M
Product$45.93M$41.06M$31.64M

Fiscal year ends in Dec 25 | Currency in USD

LNSR Financial Summary

Dec 25Dec 24Dec 23
Revenue$58.44M$53.49M$42.16M
Operating Income$-23.66M$-10.66M$-12.23M
Net Income$-34.28M$-31.40M$-14.38M
EBITDA$-23.66M$-3.00M$-8.71M
Basic EPS$-2.87$-2.73$-1.31
Diluted EPS$-2.87$-2.73$-1.31

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Mar 31, 26 | 8:30 AM
Q4 24Feb 28, 25 | 8:30 AM
Q3 24Nov 09, 24 | 8:30 AM

Peer Comparison

TickerCompany
CRBPCorbus Pharmaceuticals Holdings, Inc.
AVRAnteris Technologies Global Corp.
RPIDRapid Micro Biosystems, Inc.
MXCTMaxCyte, Inc.
TLSITriSalus Life Sciences, Inc.
CRDFCardiff Oncology, Inc.
ARAYAccuray Incorporated
OWLTOwlet, Inc.
ANIKAnika Therapeutics, Inc.
PROFProfound Medical Corp.